When.com Web Search

  1. Ads

    related to: merck and co drugs

Search results

  1. Results From The WOW.Com Content Network
  2. Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Merck_&_Co.

    Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]

  3. Category:Drugs developed by Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed_by...

    Drugs developed by Schering-Plough (42 P, 1 F) Pages in category "Drugs developed by Merck & Co." The following 131 pages are in this category, out of 131 total.

  4. Merck Group - Wikipedia

    en.wikipedia.org/wiki/Merck_Group

    The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...

  5. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/news/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.

  6. Germany's Merck In Talks To Buy Cancer Drug Maker ... - AOL

    www.aol.com/germanys-merck-talks-buy-cancer...

    On Monday, Germany-based Merck KGaA (OTC:MKGAF) (OTC:MKKGY) reacted to press reports and confirmed advanced discussions with SpringWorks Therapeutics Inc (NASDAQ:SWTX), which has a market ...

  7. Merck raises 2024 profit forecast on strong sales of cancer ...

    www.aol.com/news/merck-raises-2024-profit...

    Merck's new forecast includes a $0.26 per share charge for its $680 million acquisition of cancer drug developer Harpoon Therapeutics, which closed in the first quarter of 2024, the company said.